CTMX — CytomX Therapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1501989 ·
Last close
$1.94
Market Cap
$422.93M
52W High
$8.21
52W Low
$1.90
ADV30
4,617,593
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,688,000 — -23,502,000 -19,998,000 364,679,000 33,963,000 79,791,000
Jun 2026 1,418,000 — -23,781,000 -20,666,000 381,226,000 17,224,000 79,158,000
Mar 2026 10,258,000 — -19,672,000 -18,248,000 359,358,000 28,828,000 39,414,000
Dec 2025 663,000 — -27,932,000 -26,510,000 151,566,000 12,667,000 52,558,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-82,408,000
Investing CF
$-200,804,000
Financing CF
$251,894,000
CapEx
$-347,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.28
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-750,863,000
Inventory
—
Receivables
$37,494,000
ST Investments
$313,056,000
EBIT TTM
$-87,153,000
Pretax Income TTM
$-79,422,000
Interest Exp TTM
—
Analysts
8

Yahoo Snapshot (yfinance, live)

Total Revenue
$14,028,000
EBITDA
$-93,664,000
Free Cash Flow
$-50,412,376
Enterprise Value
$133,838,776
Total Cash
$347,980,000
Total Debt
$4,388,000
Shares Out
218,004,920
Trailing EPS
$-0.51
Book Value
$1.31
ROE
-43.6%
ROA
-22.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 76,201,000 -22,364,000 -17,368,000 151,566,000 52,558,000 99,008,000 -75,587,000
Dec 2024 138,103,000 24,995,000 31,869,000 120,533,000 120,989,000 -456,000 -86,231,000
Dec 2023 101,214,000 -6,484,000 -569,000 201,792,000 249,239,000 -47,447,000 -56,035,000
Dec 2022 53,163,000 -101,335,000 -99,317,000 260,891,000 346,642,000 -85,751,000 -110,788,000

TTM Snapshot

Revenues TTM
$18,302,000
NetIncome TTM
$-79,653,000
OpCashFlow TTM
—
Assets (Latest)
$381,226,000
Forward EPS
$-0.52

Max Pain — expiry 2028-01-21

max pain strike: $1.50 · spot: $1.88 · call oi: 1,617 · put oi: 89
Expected Move to 2028-01-21: ±$2.10 (111.70%) — implied range $-0.22 – $3.98 · ATM straddle on $2.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
PRTA PROTHENA CORP PUBLIC LTD CO $424.15M $8.26 —
OVID Ovid Therapeutics Inc. $418.98M $2.22 —
OCS Oculis Holding AG $417.01M $7.51 —
AVTX Avalo Therapeutics, Inc. $412.28M $7.13 —
EPRX EUPRAXIA PHARMACEUTICALS INC. $437.41M $6.62 —

News headlines (Yahoo Finance, 1h cache)

CytomX Therapeutics Announces Milestone Achievement in Strategic Collaboration with Regeneron in the Field of Conditionally Activated Bispecifics
2026-11-17 21:15 · Yahoo
CytomX (CTMX) Q3 2026 Earnings Call Transcript
2026-11-06 08:58 · Yahoo
CytomX Therapeutics Q3 Earnings Call Highlights
2026-11-06 03:14 · Yahoo
CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates
2026-11-05 21:45 · Yahoo
CytomX Therapeutics: Q3 Earnings Snapshot
2026-11-05 21:31 · Yahoo
CytomX Therapeutics Announces Q3 2026 Financial Results and Provides Business Update
2026-11-05 21:15 · Yahoo
CytomX Therapeutics to Present at Upcoming November Investor Conferences
2026-11-02 13:00 · Yahoo
CytomX Therapeutics to Report Third Quarter 2026 Financial Results on November 5, 2026
2026-10-29 12:00 · Yahoo
CytomX Therapeutics to Present at Upcoming September Investor Conferences
2026-09-01 12:00 · Yahoo
CytomX Therapeutics Inc (CTMX) (Q2 2026) Earnings Call Highlights: Varetta M Advances Toward ...
2026-08-07 05:03 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.